Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | PTPRA | P18433 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21298 | 0.92 | PTPRA (0.56) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Benzene SCHEMBL11747977 | 0.92 | PTPRA (0.56) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| SCHEMBL29676689 | 0.92 | PTPRA (0.56) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Acetic Acid SCHEMBL27435803 | 0.91 | CYP1A2 (0.53) | SMN1; SMN2POLBRAB9ANPC1PTPRA | |
| Iodide SCHEMBL2108436 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Water SCHEMBL5531145 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| SCHEMBL988403 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Water SCHEMBL29453010 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Hydrochloric Acid SCHEMBL334937 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA | |
| Water SCHEMBL29453011 | 0.90 | PTPRA (0.55) | SMN1; SMN2POLBRAB9ANPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6028231-A | Process for preparing 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-02-22 | — | — | US | claimed |
| EP-1957437-B1 | PROCESS FOR PRODUCING ALPHA,BETA-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORP (JP) | 2017-05-03 | — | — | EP | disclosed |
| US-7732644-B2 | Process for producing α,β-unsaturated aldehyde compounds | KAO CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20090171124-A1 | PROCESS FOR PRODUCING ALPHA, BETA-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-1957437-A1 | PROCESS FOR PRODUCING ALPHA,BETA-UNSATURATED ALDEHYDE COMPOUNDS | Kao Corporation (JP) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007063703-A1 | PROCESS FOR PRODUCING α,β-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORPORATION (JP) | 2007-06-07 | — | — | WO | disclosed |
| US-7169749-B1 | Aldol condensation carried out in an inert organic solvent, and reduction of the corresponding unsaturated aldehydes in the presence of copper/zinc catalysts, the process being carried out continuously under isothermal conditions in a narrow temperature range | KAO CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-1212272-B1 | METHOD FOR PRODUCING ALKYL-SUBSTITUTED BUTENOLS | KAO CORP (JP) | 2003-12-10 | — | — | EP | disclosed |
| WO-2001021568-A9 | METHOD FOR PRODUCING ALKYL-SUBSTITUTED BUTENOLS | COGNIS DEUTSCHLAND GMBH (DE) | 2003-11-27 | — | — | WO | disclosed |
| EP-1212272-A1 | METHOD FOR PRODUCING ALKYL-SUBSTITUTED BUTENOLS | Cognis Deutschland GmbH & Co. KG (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-0937018-B1 | PROCESS FOR PREPARING 2-METHYL-4-(2,2,3-TRIMETHYL-CYCLOPENT-3-EN-1-YL)-BUT-2-EN-1-OL | COGNIS DEUTSCHLAND GMBH (DE) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001021568-A1 | METHOD FOR PRODUCING ALKYL-SUBSTITUTED BUTENOLS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2001-03-29 | — | — | WO | disclosed |
| US-6028231-A | Process for preparing 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-02-22 | — | — | US | disclosed |
| EP-0937018-A1 | PROCESS FOR PREPARING 2-METHYL-4-(2,2,3-TRIMETHYL-CYCLOPENT-3-EN-1-YL)-BUT-2-EN-1-OL | Henkel Kommanditgesellschaft auf Aktien (DE) | 1999-08-25 | — | — | EP | disclosed |
| WO-1998017613-A1 | PROCESS FOR PREPARING 2-METHYL-4-(2,2,3-TRIMETHYL-CYCLOPENT-3-EN-1-YL)-BUT-2-EN-1-OL | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1998-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090171124-A1 | PROCESS FOR PRODUCING ALPHA, BETA-UNSATURATED ALDEHYDE COMPOUNDS | ADH1C, ADH1A, ADH5 | SMN1; SMN2 2919/4885POLB 985/4885RAB9A 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.